___

• 1. Health Canada. Important drug safety information: RISPERDAL*(risperidone) and cerebrovascular adverse events in placebo-controlled dementia trials. Toronto: Janssen-1. Ortho, 2002.
• 2. Gill SS, Rochon PA, Herrmann N, Lee PE, Sykora K, Gunraj N, Normand SL, Gurwitz JH, Marras C, Wodchis WP, Mamdani M. Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study. BMJ 2005; 330:445.
• 3. European Pharmacovigilance Working Party (PhVWP). Public assessment report on antipsychotics and cerebrovascular accident. London: Medicines and Healthcare Products Regulatory Agency, 2006.
• 4. Douglas IJ, Smeeth L. Exposure to antipsychotics and risk of stroke: self controlled case series study. BMJ 2008; 337:1227.
• 5. Liperoti R, Gambassi G, Lapane KL, Chiang C, Pedone C, Mor V, Bernabei R. Cerebrovascular events among elderly nursing home patients treated with conventional or atypical antipsychotics. J Clin Psychiatry 2005; 66:1090-1096.
• 6. Parker C, Coupland C, Hippisley-Cox J. Antipsychotic drugs and risk of venous thromboembolism: nested case-control study. BMJ 2010; 341:4245.
• 7. Herrmann N, Mamdani M, Lanctôt KL. Atypical antipsychotics and risk of cerebrovascular accidents. Am J Psychiatry 2004; 161:1113-1115.
• 8. Herrmann N, Lanctôt KL. Do atypical antipsychotics cause stroke? CNS Drugs 2005; 19:91-103.
• 9. Sacchetti E, Turrina C, Valsecchi P. Cerebrovascular accidents in elderly people treated with antipsychotic drugs: a systematic review. Drug Saf 2010; 33:273-288.
• 10. Layton D, Harris S, Wilton LV, Shakir SA. Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia. J Psychopharmacol 2005; 19:473-482.